Great Post and you have summarised exactly my thoughts and previous posts . I am enormously impressed with the discipline of the management team in with aggressive but well thought through costed growth proving out models and executing ruthlessly on them ie US expansion to market leadership without a PMA , UK pivoting quickly back to burns , India private system to educate surgeons then 64 tenders into the public system first one already approved plus developing a public system model for more high volume emerging markets , growing Europe distributor model out of success in Germany - evolving new products on platform technology with surgeon input and RWE ie MTX from BTM whilst partnering to develop breakthrough products like Hernia and Mesh with large TAM. Underpin this with increasing insurance in production capacity and professional skills and your on a winner for the long term . My only criticism is I don’t think we leverage our MC enough to expand by sensible M&A with so much underfunded small players still existing with great IP and little commercial potential. Thank you for your post I have quite a few in the bottom drawer and will be topping up with some trading parcels if it hits a $1.38 DYOR and GLTAH.
PNV Price at posting:
$1.43 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)